# Phase 31 End-to-End Anti-Workaround Audit

Contract: `phase31-end-to-end-anti-workaround-audit-v1`

**Disposition:** PASS

This is an architecture and authority-boundary audit for the Phase31 SEC Form-4 insider-transaction research path. It does not itself accept the Phase31 scientific result. Final scientific disposition is produced only by the independent negative validator followed by the Phase31 closeout runner against the locally generated evidence.

## Audit scope

- The independent negative validator reconstructs development predictor lineage, exact stock/SPY path availability, split-crossing censorship, chronology, and candidate sample counts without importing `phase31_development`.
- The protected predictor artifact is hash-bound only. Protected predictor rows are not parsed and protected returns are not read.
- The independent negative proof relies only on preregistered mandatory selection sample gates. No threshold is changed after observing results.
- No runner-up substitution is permitted.
- No Phase31 module is imported by discovery, operations, portfolio, risk, control-plane, or execution authority.
- Provider writes, broker reads/writes, order writes, PAPER submits, LIVE writes, and automation writes remain zero/disabled.
- Automatic broker failover remains disabled.
- A Phase31 `ACCEPTED_NEGATIVE` disposition does not satisfy the Phase32 signal-to-trade entry condition.

## Anti-workaround findings

1. **Independent implementation boundary — PASS.** The closeout validator statically rejects any import of the Phase31 development implementation by the independent validator.
2. **Protected holdout blindness — PASS.** The independent validator may verify the frozen protected predictor SHA-256 but contains no protected predictor parquet read and no protected-return path.
3. **Frozen sample gates — PASS.** The independent proof uses the preregistered selection minima: 750 raw rows, 250 signal sessions, and 250 unique tickers.
4. **No post-result family substitution — PASS.** Exactly the four frozen Phase31 hypotheses remain the tested family; no runner-up or newly invented candidate can replace a failed candidate.
5. **No execution authority leakage — PASS.** Phase31 remains research-only and is disconnected from runtime trading authority.
6. **Downstream gate integrity — PASS.** Negative research evidence may be accepted as scientifically complete but cannot be relabeled as supported alpha or used to enter signal-to-trade construction.

## Result boundary

The independent closeout runner must fail closed unless it verifies all four candidate sample summaries against the frozen development evidence, proves that every candidate fails at least one mandatory sample gate, confirms empty survivors/winners/finalists, confirms zero protected candidate/return reads, and confirms the protected holdout remains unconsumed.
